Nuvalent Inc (NUVL)
99.10
-1.95
(-1.93%)
USD |
NASDAQ |
Sep 27, 16:00
99.01
-0.09
(-0.09%)
After-Hours: 20:00
Nuvalent Cash from Investing (Quarterly): 16.21M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 16.21M |
| March 31, 2024 | -206.77M |
| December 31, 2023 | -56.26M |
| September 30, 2023 | 38.40M |
| June 30, 2023 | 1.594M |
| March 31, 2023 | -127.26M |
| December 31, 2022 | -65.40M |
| September 30, 2022 | 17.57M |
| Date | Value |
|---|---|
| June 30, 2022 | 24.11M |
| March 31, 2022 | 13.06M |
| December 31, 2021 | -163.46M |
| September 30, 2021 | -56.57M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-206.77M
Minimum
Mar 2024
38.40M
Maximum
Sep 2023
-35.30M
Average
--
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | -1.319B |
| Replimune Group Inc | 29.77M |
| Moderna Inc | 1.649B |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.16M |
| Cash from Financing (Quarterly) | 4.137M |
| Free Cash Flow | -130.44M |
| Free Cash Flow Per Share (Quarterly) | -0.6371 |
| Free Cash Flow Yield | -2.12% |